March 9, 2020 / 11:50 AM / 25 days ago

BRIEF-Aim ImmunoTech Says National Institute Of Infectious Diseases In Japan Will Begin Testing Co's Drug Ampligen As A Potential Treatment For Covid-19

March 9 (Reuters) - AIM ImmunoTech Inc:

* AIM IMMUNOTECH INC - NATIONAL INSTITUTE OF INFECTIOUS DISEASES IN JAPAN WILL BEGIN TESTING AIM’S DRUG AMPLIGEN AS A POTENTIAL TREATMENT FOR COVID-19 Source: (bit.ly/3aJvbsh) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below